IL82104A0 - Recombinant vaccinia virus expressing human retrovirus genes and method for producing htlb-iii envelope proteins - Google Patents
Recombinant vaccinia virus expressing human retrovirus genes and method for producing htlb-iii envelope proteinsInfo
- Publication number
- IL82104A0 IL82104A0 IL82104A IL8210487A IL82104A0 IL 82104 A0 IL82104 A0 IL 82104A0 IL 82104 A IL82104 A IL 82104A IL 8210487 A IL8210487 A IL 8210487A IL 82104 A0 IL82104 A0 IL 82104A0
- Authority
- IL
- Israel
- Prior art keywords
- htlb
- producing
- vaccinia virus
- expressing human
- envelope proteins
- Prior art date
Links
- 101710091045 Envelope protein Proteins 0.000 title 1
- 101710188315 Protein X Proteins 0.000 title 1
- 102100021696 Syncytin-1 Human genes 0.000 title 1
- 241000700618 Vaccinia virus Species 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 241001430294 unidentified retrovirus Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84929886A | 1986-04-08 | 1986-04-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL82104A0 true IL82104A0 (en) | 1987-10-30 |
Family
ID=25305510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL82104A IL82104A0 (en) | 1986-04-08 | 1987-04-03 | Recombinant vaccinia virus expressing human retrovirus genes and method for producing htlb-iii envelope proteins |
Country Status (7)
Country | Link |
---|---|
US (2) | US5770210A (de) |
EP (1) | EP0243029A1 (de) |
JP (1) | JPS63501125A (de) |
AU (1) | AU7284287A (de) |
IL (1) | IL82104A0 (de) |
NZ (1) | NZ219909A (de) |
WO (1) | WO1987006262A1 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2606029B2 (fr) * | 1986-04-08 | 1989-02-03 | Transgene Sa | Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus |
JPH01120284A (ja) * | 1987-11-05 | 1989-05-12 | Shiro Kato | Hiv不完全粒子および該製造方法 |
IL89118A0 (en) * | 1988-02-03 | 1989-08-15 | Microgenesys Inc | Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1 |
DE3813093A1 (de) * | 1988-04-19 | 1989-11-09 | Immuno Ag | Rekombinantes plasmid, verfahren zum herstellen eines rekombinanten avipoxvirus, rekombinantes avipoxvirus und dessen verwendung |
AU3775789A (en) * | 1988-06-10 | 1990-01-05 | Applied Biotechnology, Inc. | A method of evaluating recombinant vaccines against immunodeficiency virus |
US5747324A (en) * | 1988-06-10 | 1998-05-05 | Therion Biologics Corporation | Self-assembled, defective, non-self-propagating lentivirus particles |
US5614404A (en) * | 1988-06-10 | 1997-03-25 | Theriod Biologics, Incorporated | Self-assembled, defective, non-self-propagating lentivirus particles |
US5691170A (en) * | 1989-04-18 | 1997-11-25 | Therion Biologics | Generation of hybrid genes and proteins by virus-mediated recombination |
FR2646854A1 (fr) * | 1989-05-12 | 1990-11-16 | Pasteur Institut | Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 antigenes presentant avec eux une parente immunologique |
GB8912496D0 (en) * | 1989-05-31 | 1989-07-19 | Medical Res Council | Vaccines |
US5741492A (en) * | 1996-01-23 | 1998-04-21 | St. Jude Children's Research Hospital | Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses |
US6723558B1 (en) | 1996-01-23 | 2004-04-20 | St. Jude Children's Research Hospital | Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses |
US8623379B2 (en) * | 2000-03-02 | 2014-01-07 | Emory University | Compositions and methods for generating an immune response |
AU1194802A (en) | 2000-03-02 | 2001-12-11 | Univ Emory | DNA expression vectors and methods of use |
US20040105871A1 (en) * | 2000-03-02 | 2004-06-03 | Robinson Harriet L. | Compositions and methods for generating an immune response |
US20040191260A1 (en) | 2003-03-26 | 2004-09-30 | Technion Research & Development Foundation Ltd. | Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof |
JP4554887B2 (ja) * | 2001-03-08 | 2010-09-29 | アメリカ合衆国 | 改変HIVエンベロープ、gag、およびpol遺伝子を発現するMVA |
US8022190B2 (en) | 2001-06-19 | 2011-09-20 | Technion Research & Development Foundation Ltd. | Immuno-molecules containing viral proteins, compositions thereof and methods of using |
JP2008518584A (ja) | 2004-05-27 | 2008-06-05 | セントカー・インコーポレーテツド | カニクイザルの前立腺特異的抗原 |
JP5225266B2 (ja) | 2006-05-19 | 2013-07-03 | テバ ファーマシューティカル インダストリーズ リミティド | 融合タンパク質、その使用、およびその製造方法 |
US8394385B2 (en) | 2009-03-13 | 2013-03-12 | Bavarian Nordic A/S | Optimized early-late promoter combined with repeated vaccination favors cytotoxic T cell response against recombinant antigen in MVA vaccines |
WO2012137071A2 (en) | 2011-04-06 | 2012-10-11 | Biovaxim Limited | Pharmaceutical compositions for preventing and/or treating an hiv disease in humans |
US20130101664A1 (en) | 2011-08-18 | 2013-04-25 | Donald W. Kufe | Muc1 ligand traps for use in treating cancers |
US10111946B2 (en) | 2012-06-22 | 2018-10-30 | Bavarian Nordic A/S | Poxviral vectors for low antibody response after a first priming immunization |
US20170002064A1 (en) | 2013-11-08 | 2017-01-05 | The Board Of Regents Of The University Of Texas System | Vh4 antibodies against gray matter neuron and astrocyte |
AU2015211034B2 (en) | 2014-01-29 | 2020-04-09 | Dana-Farber Cancer Institute, Inc. | Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4603112A (en) * | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
US4774175A (en) * | 1985-03-01 | 1988-09-27 | Centocor, Inc. | Immunochemical methods for the detection of antibody against HTLV-III |
GB8508845D0 (en) * | 1985-04-04 | 1985-05-09 | Hoffmann La Roche | Vaccinia dna |
US5081029A (en) * | 1985-09-25 | 1992-01-14 | Oncogen | Methods of adoptive immunotherapy for treatment of aids |
US4772547A (en) * | 1986-02-03 | 1988-09-20 | Hoffmann-La Roche Inc. | HTLV-III envelope peptides |
US4753873A (en) * | 1986-02-03 | 1988-06-28 | Cambridge Bioscience Corporation | Peptides for the diagnosis of HTLV-III antibodies, their preparation and use |
-
1987
- 1987-04-03 EP EP87302941A patent/EP0243029A1/de not_active Withdrawn
- 1987-04-03 IL IL82104A patent/IL82104A0/xx unknown
- 1987-04-08 AU AU72842/87A patent/AU7284287A/en not_active Abandoned
- 1987-04-08 NZ NZ219909A patent/NZ219909A/xx unknown
- 1987-04-08 JP JP62502550A patent/JPS63501125A/ja active Pending
- 1987-04-08 WO PCT/US1987/000802 patent/WO1987006262A1/en unknown
-
1992
- 1992-07-29 US US07/919,384 patent/US5770210A/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/467,324 patent/US5849304A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5770210A (en) | 1998-06-23 |
WO1987006262A1 (en) | 1987-10-22 |
US5849304A (en) | 1998-12-15 |
JPS63501125A (ja) | 1988-04-28 |
EP0243029A1 (de) | 1987-10-28 |
AU7284287A (en) | 1987-11-09 |
NZ219909A (en) | 1990-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL82104A0 (en) | Recombinant vaccinia virus expressing human retrovirus genes and method for producing htlb-iii envelope proteins | |
JPS6425800A (en) | T-cell epitope of hepatities b virus nucleocapside protein | |
ZA872705B (en) | Human g-csf protein expression | |
NZ217645A (en) | Recombinant viruses expressing lav/htlv-iii related epitopes and vaccine formulations | |
AR241939A1 (es) | Metodo para la recombinacion de adn de virus de viruela de ave con adn exogeno. | |
IL71991A0 (en) | Preparation of human igf and egf via recombinant dna technology | |
YU57885A (en) | Process for obtaining new human physiologically active polypeptide | |
AU7553587A (en) | Diagnostic peptides of human papilloma virus | |
EP0243929A3 (en) | Polypeptide and protein derivatives and process for their preparation | |
NZ220653A (en) | Hiv env region peptides and d-retro versions thereof | |
AU1255383A (en) | Foot and mouth disease viral antigenic peptides | |
GB8821528D0 (en) | Recombinant vaccinia virus | |
ZA862812B (en) | Antigens related to envelope glycoprotein of the virus of aids,methods of obtaining these antigens and means employed in these methods | |
GB8717770D0 (en) | Enhancing bioactivity of atrial peptides | |
EP0209543A4 (de) | Peptidfragmente menschlicher apolipoproteine, typspezifische antikörper und verwendungsverfahren. | |
ZA881621B (en) | Cyclic peptides and their preparation | |
NZ221227A (en) | Hiv envelope proteins, antigenic fragments vaccines; and diagnostic methods | |
GB2068970B (en) | Recombinant dna technique for the preparation of a protein resembling human interferon | |
AU2520692A (en) | Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus | |
NZ224393A (en) | Recombinant hiv envelope proteins and uses thereof | |
AU545758B2 (en) | Recombinant dna technique for the preparation of a protein resembling human interferon | |
ZA883878B (en) | Human immunodeficiency virus gag-encoded proteins | |
PT86162A (en) | Recombinant protein expression | |
GB2205568B (en) | Recombinant plasmids and silk-like proteins produced therefrom | |
IL83670A0 (en) | Dna coding for antigen protein of rinderpest virus and process for the preparation thereof |